Glucos Fresenius Kabi (Glucose)

Glucos Fresenius Kabi is indicated for several clinical situations where intravenous carbohydrate and fluid support are required.

• Management of hypoglycemia when oral glucose administration is not feasible.
• Fluid replacement in patients with dehydration or electrolyte loss.
• Component of parenteral nutrition regimens for patients unable to receive enteral feeding.
• Support of energy needs during peri‑operative care.
• Adjunct therapy for pediatric and neonatal patients requiring balanced carbohydrate provision.

Glucos Fresenius Kabi may be associated with a range of adverse reactions, most of which are related to its osmotic and metabolic properties.

Common

• Transient hyperglycemia, especially in patients with impaired glucose tolerance.
• Local irritation or pain at the infusion site.
• Electrolyte disturbances such as hyponatremia when large volumes are administered.
• Nausea or mild gastrointestinal discomfort.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Fluid overload with risk of pulmonary edema in patients with compromised cardiac function.
• Rare anaphylactic reactions to formulation components.

When using Glucos Fresenius Kabi, clinicians should consider several safety factors to minimize risk.

• Assess baseline blood glucose and monitor levels regularly during infusion.
• Evaluate cardiac and renal function before administering large volumes.
• Adjust infusion rate in patients at risk for fluid overload or electrolyte imbalance.
• Use aseptic technique to prevent catheter‑related infections.
• Avoid rapid bolus administration unless clinically indicated.
• Document any adverse reactions and report serious events to pharmacovigilance authorities.

Glucos Fresenius Kabi can interact with other therapies that affect glucose metabolism or fluid balance.

Avoid

• Concurrent use of high‑dose insulin without appropriate glucose monitoring.
• Co‑administration with other hyperosmolar solutions that may exacerbate fluid shifts.

Use with caution

• Diuretics, which may increase the risk of electrolyte disturbances.
• Beta‑blockers, which can mask signs of hypoglycemia.
• Corticosteroids, which may raise blood glucose levels.
• Medications that affect renal function, such as ACE inhibitors or NSAIDs.